These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 17592364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T, Hassall E, Lundborg P, Shepherd R, Radke M, Marcon M, Dalväg A, Martin S, Behrens R, Koletzko S, Becker M, Drouin E, Göthberg G.
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [Abstract] [Full Text] [Related]

  • 3. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part I. Intraesophageal pH values in distal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
    Semeniuk J, Kaczmarski M.
    Adv Med Sci; 2007 Nov; 52():199-205. PubMed ID: 18217419
    [Abstract] [Full Text] [Related]

  • 4. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP, Johnston BT, Just RJ, Castell DO.
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [Abstract] [Full Text] [Related]

  • 5. 24-hour esophageal pH monitoring in children with pathological acid gastroesophageal reflux: primary and secondary to food allergy. Part II. Intraesophageal pH values in proximal channel; preliminary study and control studies--after 1, 2, 4 and 9 years of clinical observation as well as dietary and pharmacological treatment.
    Semeniuk J, Kaczmarski M.
    Adv Med Sci; 2007 Aug; 52():206-12. PubMed ID: 18217420
    [Abstract] [Full Text] [Related]

  • 6. [Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study].
    Orsi M, Donato G, Busoni V, Naisberg G, Caruso N.
    Acta Gastroenterol Latinoam; 2011 Jun; 41(2):111-8. PubMed ID: 21894724
    [Abstract] [Full Text] [Related]

  • 7. Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.
    Størdal K, Johannesdottir GB, Bentsen BS, Knudsen PK, Carlsen KC, Closs O, Handeland M, Holm HK, Sandvik L.
    Arch Dis Child; 2005 Sep; 90(9):956-60. PubMed ID: 16113133
    [Abstract] [Full Text] [Related]

  • 8. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP, Goldwater R, Lee SM, Park DW, Kim DY, Cho KD, Boileau F, Jung WT.
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [Abstract] [Full Text] [Related]

  • 9. [Role of 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux and assessment of drug effectiveness].
    Abidin ZU, Ivashkin VT, Sheptulin AA, Trukhmanov AS, Okhlobystin AV.
    Klin Med (Mosk); 1999 Sep; 77(7):39-42. PubMed ID: 10483164
    [Abstract] [Full Text] [Related]

  • 10. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H, Yilmaz O, Kirmaz C, Aydoğdu S, Kasirga E.
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [Abstract] [Full Text] [Related]

  • 11. [Omeprazole of limited value in crying babies].
    Blokpoel RG, Broos N, de Jong-van den Berg LT, de Vries TW.
    Ned Tijdschr Geneeskd; 2010 Mar; 154():A1850. PubMed ID: 20719016
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
    Heyman MB, Zhang W, Huang B, Chiu YL, Amer F, Winter HS.
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
    [Abstract] [Full Text] [Related]

  • 13. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI, Haslam RR, Lundborg P, Davidson GP.
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [Abstract] [Full Text] [Related]

  • 14. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A.
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
    Tefera S, Hatlebakk JG, Berstad A.
    Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
    Ferrari M, Benini L, Brotto E, Locatelli F, De Iorio F, Bonella F, Tacchella N, Corradini G, Lo Cascio V, Vantini I.
    Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
    [Abstract] [Full Text] [Related]

  • 19. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R, Brecelj J, Homan M, Heuschkel R.
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):376-83. PubMed ID: 16641575
    [Abstract] [Full Text] [Related]

  • 20. Does simultaneous gastric and esophageal pH monitoring increase the diagnosis of gastroesophageal reflux disease?
    Demir H, Ozen H, Koçak N, Saltik-Temizel IN, Gürakan F.
    Turk J Pediatr; 2005 Apr; 47(1):14-6. PubMed ID: 15884623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.